|
This
course is intended for manufacturers who are planning to bring their
devices to the European market and need clinical data to support their
product claims according with the new EU Directives, which take effect
on March 21, 2010. One key change is the requirement of more
clinical data for devices placed on the market in any of the 27 EU
member nations. For clinical investigations, there will be more
scrutiny of clinical dossiers and communication between authorities,
for example, refusal from one country will be shared with all other
nations. Devicemakers need practical tools for immediate compliance
with the new requirements, that this course will provide.
Whether
you are developing an innovative product, preparing a technical dossier
for CE marking or planning a clinical study in Europe, this course will
allow you to tailor your strategy for gathering valid clinical evidence
in Europe to reach your business objectives of rapid and cost-effective
market approval. If you also plan to enter the United States market,
you will receive practical advice on actions that can be taken to
prevent costly duplication of studies for FDA approvals and clearances.
|